2008

Clementi M, Tiboni GM, Causin R, La Rocca C, Maranghi F , Raffagnato F, Tenconi R
Pesticides and Fertility: an Epidemiological Study in Northeast Italy and Review of the Literature
Reproductive Toxicology. In Press, Available online 30 May 2008

Hoeltzenbein M, Weber-Schöndorfer C, von Stackelberg L, Schaefer C.
Paternal exposure to drugs – Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute of Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract).
Med Genetik 2008; 20:166.

Wentges-van Holthe N, van Eijkeren M, van der Laan JW
Oseltamivir and breastfeeding
International Journal of Infectious Diseases. In Press Available online 1 February 2008

2007

Aguilera C, Agustí A.
Low dose of aspirin during pregnancy.
Med Clin (Barc). 2007;128:31-3.

Clementi M, Causin R, Marzocchi C, Mantovani A, Tenconi R.
A study of the impact of agricultural pesticide use on the prevalence of birth defects in northeast Italy
Reproductive Toxicology, 2007: 24: 1-8.

Goldstein LH, Dolinsky G, Grreenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrim O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M.
Pregnancy outcome of women exposed to Azathioprine during Pregnancy
Birth Defects Research (Part A) 2007; 696:701.

Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C et al.
Colchicine use in children and adolescents with Familial Mediterranean fever. Literature review and consensus statement.
Pediatrics. 2007; 119: e474-83.

Maňáková E, Hubičková Heringová L.
The risks of autoimmune diseases therapy in pregnancy.
Chem Listy. 2007; 101: s122−s125.

Meister R, Schaefer C.
Spontaneous abortion rates: Unbiased statistical estimation – with coumarins as an example (Abstract).
Reprod Toxicol. 2007; 24: 64.

Ornoy A.
Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
Reproductive Toxicology. 2007; 24(1):31-41.

Ornoy A.
Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: Are we close to prevention?
IMAJ. 2007; 9(5): 398-401.

Osovsky M, Tamary I, Merlob P.
Neonatal thrombocytosis following G-CSF treatment.
Clin Toxicol. 2007; 45:801-2.

Rahav G, Gabbay G, Ornoy A, Shechtman S, Arnon J, Diav-Citrin O.
Cytomegalovirus in pregnancy – Primary versus non-primary infection: a prospective cohort study.
Emerging Infectious Diseases. 2007; 13(11):1791-1793.

Ramió X, Aguilera C.
Selective serotonin reuptake inhibitor antidepressants in pregnancy.
Med Clin (Barc). 2007;129:194-6.

Schaefer C, Peters PWJ, Miller R (eds).
Drugs during pregnancy and lactation. Treatment options and risk assessment, 2nd ed.
Elsevier/Academic Press, Amsterdam, New York 2007.

2006

Avgil M and Ornoy A.
Herpes simplex virus and Epstein Barr virus infections in pregnancy; consequences of neonatal or intrauterine infection.
Reproductive Toxicology. 2006; 21(4):436-445.

Clementi M.
Introduction 34th Annual Conference of the European Teratology Society
Reproductive Toxicology. 2006; 22:125.

Clementi M, Di Gianantonio E, Ponchia R, Petrella M, Andrisani A, Tenconi R .
Pregnancy outcome after genetic counselling for prenatal diagnosis of unexpected chromosomal anomaly
European Journal of Obstetrics Gynecology Reproductive Biology. 2006; 128: 77-80.

Clementi M, Di Gianantonio Elena.
Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps
Therapeutic Drug Monitoring. 2006; 28:576.

Ergaz Z, Ornoy A.
PARVOVIRUS B19 in pregnancy.
Reproductive Toxicology. 2006; 21(4): 421-435.

Furlan A, Vianello F, Clementi M, Prandoni P.
Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report
Haematologica/the Hematology . 2006; 91:19-20.

Hubičková Heringová L, Maňáková E.
CZTIS Comparison of the treatment by psychotropic and antiepileptic drugs.
Neuroendocrinology Letters. 2006; 27: (Suppl.2) 74-77.

Klinger G, Levinson-Castiel R, Merlob P.
Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: Still controversial.
Arch Pediatr Adolesc Med. 2006; 160:856.

Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G.
Neonatal abstinence syndrome following in utero exposure to selective serotonin reuptake inhibitors in term infants.
Arch Pediatr Adolesc Med. 2006; 160:173-6.

López P, Aguilera C. Med Clin
Safety of antimigraine drugs during pregnancy.
(Barc). 2006;126:793-5.

Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Ca.
Anti-inflammatory and immunosuppressive drugs and reproduction
Arthritis Research Therapy. 2006; 8: 209- 318.

Ornoy A, Diav-Citrin O.
Fetal effects of primary and secondary cytomegalovirus infection in pregnancy.
Reproductive Toxicology. 2006; 21(4):399-409.

Ornoy A.
Intrauterine infections: introductory comments.
Reproductive Toxicology. 2006; 21(4):343-344.

Ornoy A.
Neuroteratogens in man: an overview with special emphasis on antiepileptic drugs in pregnancy.
Reprod Toxicol. 2006; 22(8):214-226.

Ornoy A, and Tenenbaum A.
Pregnancy outcome following infections by Coxsackie, Echo, Measles, Mumps, Hepatitis, Polio and Encephalitis viruses.
Reproductive Toxicology. 2006; 21(4):446-457.

Ornoy A, Weijnberg R, Diav-Citrin O.
The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment.
Reproductive Toxicology. 2006; 22:578-579.

Raz-Dubnov G, Shapiro R, Merlob P.
Maternal lamotrigine treatment and elevated neonatal gamma-glutamyl transpeptidase.
Pediatr Neurol. 2006; 35:220-2.

Sharan H, Kaplan B, Weizer N, Sulkes J, Merlob P.
Early screening of postpartum depression using the Edinburgh Postnatal Depression Scale.
Inter J Risk Safety Med. 2006; 19:1-6.

Schaefer C.
Exposure to vitamin K antagonists during pregnancy.
Clin Adv Hematol Oncol. 2006;4:509-10.

Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P.
Vitamin K antagonists and pregnancy outcome
Thrombosis and Haemostasis. 2006; 95: 949-957.

2005

Aguilera C, Izarra A.
Toxic substance abuse during pregnancy.
Med Clin (Barc). 2005;125:714-6.

Bar-Oz B, Clementi M, Giantonio ED, Greenberg R, Beer M, Merlob P, Arnon J, Ornoy A, Zimmerman DM, Berkovitch M.
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
European Journal of Obstetrics Gynecology Reproductive Biology. 2005; 119:176-9.

Bernat M, Aguilera C.
Treatment of severe hypertension during pregnancy.
MedClin (Barc). 2005;124:634-5.

Benyamini L, Merlob P, Shtahl B, Braunstein R, Bortnik O, Bulkowstein M, Zimmerman D, Berkovitch M.
The safety of the amoxicillin/clavulanic acid and cefuroxime during lactation.
Ther Drug Monit. 2005; 27:499-502.

Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, Givan C, Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J.
International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?
Br Med J. 2005; 330:571-7.

De Santis M, Di Gianantonio E, Straface G, Cavaliere AF, Caruso A, Schiavon F, Berletti R, Clementi M.
Ionizing radiations in pregnancy and teratogeneis – A review of literature
Reproductive toxicology. 2005; 20:323-329.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.
Safety of Haloperidol and Penfluridol in Pregnancy: A Multicenter, Prospective, Controlled Study
Journal of Clinical Psychiatry. 2005; 66:317-322.

Diav Citrin O, Arnon J, Shechtman S, Schaefer C, Tonningen MR, Clementi M, Santis M, Robert Gnansia E, Valti E, Malm H, Ornoy A.
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study
Alimentary Pharmacology and Therapeutics. 2005; 21: 269-275.

Dubnov G, Fogelman R, Merlob P.
Prolonged QT interval in a newborn to a fluoxetine-treated mother.
Arch Dis Child. 2005; 90:972-3.

Garbis H, Elefant E, Diav-Citrin O, Mastroiacovo P, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Pinilla Rodriguez E, Robert-Gnansia E, Merlob P, PeikeR G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M.
Pregnancy outcome after exposure to ranitidine and other H2-blockers A collaborative study of the European Network of Teratology Information Services
Reproductive Toxicology. 2005; 19:453-458.

Merlob P, Sapir O, Sulkes J, Fisch B.
The prevalence of major congenital malformations during two periods of time, 1986 - 1994 and 1995 - 2002 in newborns conceived by assisted reproduction technology.
Eur J Med Genet. 2005; 48:5-11.

Ornoy A.
Growth and neurodevelopmental outcome of children born to mothers with pre-gestational and gestational diabetes: An invited review.
Pediatric Endocrinology Reviews. 2005; 3(2): 43-54.

Schaefer C, Hannemann D, Meister R.
Post-marketing surveillance system for drugs in pregnancy – 15 years experience of ENTIS.
Reprod Toxicol. 2005; 20: 331-43.

Tellum R, Shechtman S, Arnon J, Diav-Citrin O, Bar-Oz B, Berkovitch M, Ornoy A.
Pregnancy outcome after gestational exposure to the new macrolides: a prospective controlled cohort study.
Reprod Toxicol. 2005; 20(3): 484-5.

2004

Aguilera C, Danés I, Agustí A.
Therapeutic consultation services about teratology: A growing need for drug information.
Reprod toxicol 2004;19:239-260.

Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, Bortnik O, Arnon J, Ornoy A.
First-trimester exposure to amoxycillin/ clavulanic acid: a prospective, controlled study.
Br J Clin Pharmacol. 2004; 58(3):298-302.

Clementi M, ArnonJ, Ornoy A.
Nato advanced research workshop on "Drugs in pregnancy: consensus conference on Teratogen Information Services". Prague, 16-18 April, 2004: Introductory comments.
Reproductive Toxicology. 2004; 19:239-240

Diav- Citrin O, Arnon J, Shechtman S, Wajnberg R, Ornoy A.
Treatment of thyrotoxicosis and hypothyroidism in pregnancy.
Reproductive Toxicology. 2004; 19:243-244

Figueras A, Narváez E, Aguilera C, Laporte JR.
Securing reproductive rights.
Lancet 2004;363:989.

Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A.
Pregnancy outcome after first trimester exposure to corticosteroids: A prospective controlled study.
Reprod. Toxicol. 2004; 18:93-101.

Jaber L, Karim JA, Jaurdat AM, Fausi M, Merlob P.
Awareness of folic acid for prevention of neural tube defects in a community with high prevalence of consanguineous marriages.
Ann Génétique. 2004; 47:69-75.

Jelínek R.
The contribution of new findings and ideas to the old principles of teratology.
Reproductive toxicology. 2004; 20:295-300.

Mendoza G, Aguilera C.
Safety of antipsychotic drug during pregnancy.
Med Clin (Barc). 2004;122:475-6.

Merlob P.
Drug exposure during pregnancy: Pharmaceutical advertising.
Reprod Toxicol. 19:260.

Merlob P.
Infants of mothers with malignant disease (IMMD).
Reprod Toxicol. 2004; 19:251.

Merlob P, Stahl B, Sulkes J.
Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel.
Eur J Pediatr. 2004; 163:135-9.

Ornoy A, Arnon J, Shechtman S, Diav- Citrin O.
The developmental effects of maternal antiepileptic drugs with special emphasis on carbamazepine.
Reproductive Toxicology. 2004; 19:248-249.

Ratzon N , Ornoy A, Pardo A, Margolin R, Hatch M.
Developmental evaluation of children born to mothers occupationally exposed to waste anesthetic gases.
Birth Defects Research, Part A, Clinical and Molecular Teratology. 2004; 70:476-482.

Rebordosa C, Aguilera C.
Safety of antiepileptic drugs during pregnancy.
Med Clin (Barc). 2004;122:675-6.

Schaefer C.
Are new anticonvulsants safer than classical? (Abstract).
Reprod Toxicol. 2004; 19: 247-8.

Schaefer C.
Major birth defects and classical anticonvulsants – How to resume the risk? (Abstract)
Reprod Toxicol. 2004; 19: 244-5.

2003

Aguilera C, Agustí A.
Anticoagulation of pregnant women with mechanical heart valves.
Med Clin (Barc). 2003;121:755-6.

Aguilera C, Agustí A.
Safety of glucocorticoid administration during pregnancy.
Med Clin (Barc). 2003;120:395-6.

Bar J, Stahl B, Hod M, Wittenberg C, Pardo J, Merlob P.
Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience.
Am J Med Genet. 2003; 116A:31-6.

Clementi M, Giavini E, Mantovani A.
Avoidance of bioflavonoid supplements during pregnancy
The Lancet. 2003; 361:261-262.

Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A.
Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.
J. Allergy Clin. Immunol. 2003; 111:1239-1243.

Diav-Citrin O, Shechtman S, Arnon J, Lubart I, Ornoy A.
Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.
Am. J. Obstet. Gynecol. 2003; 188:282-285.

Merlob P, Sharan H, Weiss S.
Maternal report of prenatal alcohol use.
Pediatrics. 2003; 111:443-4.

Naor N, Merlob P.
To dye or not to dye: A randomized, clinical trial of a triple dye-alcohol regime versus dry cord care.
Pediatrics. 2003; 112:2001.

Heringová L, Jejínek R, Dostál M.
Cell-cycle alterations underlie cyclophosphamide-induced teratogenesis in the chick embryos.
Birth Defects Research. Part A: Clinical and Molecular Teratology. 2003; 67: 438-443.

Schaefer C.
Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Birth Defects Research A 2003; 67:591-4.

2002

Clementi M, Di Gianantonio E, Ornoy A.
Teratology information services in europe and their contribution to the prevention of congenital anomalies.
Community Genetics. 2002; 5: 5-7.

2001

Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, and Clementi M.
Adverse effects of prenatal methimazole exposure
Teratology. 2001; 64: 262-266.

Garne E, Stoll C, Clementi M, and Euroscan group.
Evaluation of Prenatal Diagnosis of Congenital Heart Diseases by Ultrasound: Experience from 20 European Registries
Ultrasound in Obstetrics and Gynecology. 2001; 17: 386-391.

2000

1999

Clementi M, Di Gianantonio E, Pelo E, Mammi I, Tenconi R.
Methimazole embryopathy. Delineation of the phenotype
American Journal of Medical Genetics. 1999; 83:43-46.

Mastroiacovo P, Mazzone T, Addis A, Elephant E, Carlier P, Vial T, Garbis H, Robert E, Bonati M, Ornoy A, Finardi A, Schaffer C, Caramelli L, Rodriguez-Pinilla E, Clementi M.
High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study
Teratology . 1999; 59: 7-11.